Global Blood Therapeutics
GBT
#2830
Rank
ยฃ3.79 B
Marketcap
ยฃ56.29
Share price
0.00%
Change (1 day)
136.20%
Change (1 year)

Revenue for Global Blood Therapeutics (GBT)

Revenue in 2022 (TTM): ยฃ0.18 Billion

According to Global Blood Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ0.19 Billion. In 2021 the company made a revenue of ยฃ0.14 Billion an increase over the revenue in the year 2020 that were of ยฃ90.82 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Global Blood Therapeutics from 2014 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) ยฃ0.18 B25.65%
2021 ยฃ0.14 B58.85%
2020 ยฃ90.82 M5549.98%
2019 ยฃ1.6 M
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA